NS Pharma, Inc赞助的临床试验
总计2366个结果
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.完全的
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.终止
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.完全的
-
University of Illinois at ChicagoAstellas Pharma US, Inc.完全的
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.完全的
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.撤销
-
Merck Sharp & Dohme LLCCentocor, Inc.; Essex Pharma GmbH完全的
-
Hospital Universitario Ramon y CajalNovartis; Astellas Pharma Inc未知
-
University of Texas Southwestern Medical CenterAstellas Pharma Inc尚未招聘
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.尚未招聘
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.招聘中
-
Klus Pharma Inc.Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.招聘中
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.招聘中
-
Navire Pharma Inc., a BridgeBio companyBristol-Myers Squibb招聘中
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.招聘中
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.终止
-
Brillian Pharma Inc.Accutest Research Laboratories (I) Pvt. Ltd.完全的
-
Seoul National University Bundang HospitalAstellas Pharma Korea, Inc.完全的
-
Eli Lilly and CompanyAlgorithme Pharma Inc; CoLucid Pharmaceuticals完全的
-
Wake Forest University Health SciencesAstellas Pharma US, Inc.终止
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.完全的
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.完全的
-
Aiden AbidovAstellas Pharma US, Inc.未知
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的
-
Hospital Clinic of BarcelonaAstellas Pharma Inc; Fresenius AG终止
-
Yale UniversityBristol-Myers Squibb; Astellas Pharma US, Inc.完全的
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019.完全的乳腺肿瘤 | 乳腺疾病 | 转移瘤、肿瘤
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019.完全的
-
EIP Pharma IncNational Institute on Aging (NIA); Worldwide Clinical Trials; CervoMed, Inc主动,不招人
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
APR Applied Pharma Research s.a.Cavendish Impact Foundation; Clinigen, Inc.; Nephron Pharmaceuticals, Inc.不再可用
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的去势抵抗性前列腺癌美国, 加拿大, 法国, 西班牙, 英国, 澳大利亚, 波兰, 德国, 奥地利, 比利时, 荷兰, 意大利, 智利, 南非, 阿根廷
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的
-
Seoul National University HospitalKyowa Hakko Kirin Pharma, Inc.; Jeil-Kirin Pharmaceutical Inc.完全的
-
CM Chungmu HospitalKorea United Pharm. Inc.未知
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.主动,不招人前列腺癌 | 前列腺癌 | 非转移性去势抵抗性前列腺癌香港, 加拿大, 中国, 德国, 西班牙, 荷兰, 英国, 大韩民国, 台湾, 澳大利亚, 丹麦, 法国, 美国, 新加坡, 波兰, 马来西亚, 火鸡, 比利时, 阿根廷, 泰国, 斯洛伐克, 巴西, 芬兰, 意大利, 塞尔维亚, 乌克兰, 瑞典, 奥地利, 智利, 希腊, 新西兰, 俄罗斯联邦